The pharmaceutical group, which has been offering social and financial support to employees with cancer or close to patients in France since 2017, has decided to extend this programme worldwide with 100% salary continuation. The move follows positive feedback on the scheme, Florence Cauvet, HR director for France at Sanofi, tells mind RH.
‘Cancer and Work: Acting Together’, this is the name of the programme launched by Sanofi worldwide at the beginning of the year. Employees will be able to benefit from various measures if they receive a medical diagnosis of cancer, whether they are on sick leave or remain at work. This scheme adds a second pillar to a global social protection base for the group’s employees, with the company having also created a 14-week birth leave for all new parents, “regardless of country, gender or sexual orientation”.
Social, emotional and financial support
The pharmaceutical group promises employees suffering from cancer the option of adjusting their working hours. In the event of burdensome treatment and sick leave, Sanofi guarantees to maintain salary and benefits for one year.
Do you have information to share with us?
Article authors
Antoine Piel
Section Head at Mind HR